Skip to main content

and
  1. Article

    Open Access

    Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer

    Little is known about chemoradiotherapy (CRT) in elderly patients with a locally advanced oesophageal cancer (OC). The aim of our study was to evaluate the tolerance and the outcome of elderly patients older t...

    D Tougeron, F Di Fiore, S Thureau, N Berbera, I Iwanicki-Caron in British Journal of Cancer (2008)

  2. Article

    Open Access

    Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

    The predictive value of KRAS mutation in metastatic colorectal cancer (MCRC) patients treated with cetuximab plus chemotherapy has recently been suggested. In our study, 59 patients with a chemotherapy-refractory...

    F Di Fiore, F Blanchard, F Charbonnier, F Le Pessot, A Lamy in British Journal of Cancer (2007)

  3. Article

    Open Access

    Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

    A recent phase I study showed that weekly cisplatin, irinotecan and concurrent radiotherapy can be administered with moderate toxicity in patients with oesophageal cancer. Patients with no prior treatment and ...

    P Michel, A Adenis, F Di Fiore, E Boucher, M P Galais, L Dahan in British Journal of Cancer (2006)

  4. Article

    Open Access

    ‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’

    This phase II trial was performed to evaluate the efficacy and tolerability of a new combination of Uracil/Ftorafur (UFT®)/leucovorin (LV) and oxaliplatin in patients (pts) with metastatic colorectal cancer (MCRC...

    J Bennouna, H Perrier, B Paillot, F Priou, J H Jacob, M Hebbar in British Journal of Cancer (2006)

  5. No Access

    Article

    Extended necrosis of the oesophageal wall after photodynamic therapy: Report of two cases

    Nous rapportons 2 observations de nécrose étendue de l'oesophage après photochimiothérapie par laser à colorant. Dans les 2 cas, le traitement laser était indiqué pour une petite récidive d'un carcinome oesoph...

    P. Hochain, Dr P. Ducrotte, J. Y. Touchais, B. Paillot in Lasers in Medical Science (1993)

  6. No Access

    Chapter and Conference Paper

    The Value of Preoperative Radiotherapy in Esophageal Cancer: Results of a Study by the EORTC

    Attempts to combine radiation therapy and surgery in operable patients with carcinoma of the esophagus started 30 years ago. The first reported surgical series showed a low rate of resectability and a high pos...

    M. Gignoux, A. Roussel, B. Paillot in Combined Modality Therapy of Gastrointesti… (1988)

  7. No Access

    Chapter and Conference Paper

    Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group

    Radiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson [1], The 1-year survival rate var...

    A. Roussel, J. H. Jacob, P. Haegele in Combined Modality Therapy of Gastrointesti… (1988)